Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 ,inter alia, to consider and approve Financial results for the quarter and year ended March 31, 2025 and recommendation of Dividend, if any, for the financial year ended March 31, 2025